Company intelligence / Profile preview

Sileishi Biotechnology

Shanghai, Shanghai, China
Ownership
Private
Employees
~30
Development stage
Other
01

Overview

Sileishi Biotechnology is a China-based biopharmaceutical company specializing in the development of next-generation RNA therapeutics. The company focuses on messenger RNA (mRNA) and circular RNA (circRNA) technologies, supported by proprietary lipid nanoparticle (LNP) delivery platforms. Sileishi aims to address unmet medical needs in oncology, infectious diseases, and rare disorders. Led by industry veterans with extensive experience from global pharmaceutical firms like Merck KGaA, the company is advancing a pipeline of innovative RNA-based candidates through pre-clinical development. By optimizing the stability and translation efficiency of RNA molecules, Sileishi Biotechnology seeks to provide transformative treatments for patients worldwide.

Therapeutic areas
OncologyRare DiseasesInfectious Diseases
Modalities
mRNA-based drugsRNA therapyCircular RNALipid nanoparticle delivery therapy
Industry
Biotech
02

Drug pipeline

1 asset

SL4903

1

Beyond the preview

Go deeper on Sileishi Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sileishi Biotechnology.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call